Live Price
Live Volume
Clearmind Medicine Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
| Open | $5.42 |
|---|---|
| Close | $4.95 |
| Low | $4.93 |
| Low Change | -0.49 (-8.96%) |
| High | $5.58 |
| High Change | +0.16 (+3.03%) |
| Range | $0.65 |
| Volume | 3.908K |
| Dollar Volume | $19.34K |
Premarket
*No Trades in Segment
Overnight
| Open | $6.06 |
|---|---|
| Close | $6.06 |
| Low | $6.06 |
| Low Change | 0.00 (0.00%) |
| High | $6.06 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 452 |
| Dollar Volume | $2.74K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
| Open | $5.76 |
|---|---|
| Close | $5.09 |
| Low | $5.09 |
| Low Change | -0.67 (-11.63%) |
| High | $5.76 |
| High Change | +0.00 (+0.00%) |
| Range | $0.67 |
| Volume | 5.514K |
| Dollar Volume | $28.07K |
Premarket Yesterday
*No Trades in Segment
Clearmind Medicine News
6 months agoinvesting.comClearmind Medicine stock surges 95% on Japan patent filing
- 6 months agoinvesting.com
Clearmind Medicine stock gains on Johns Hopkins trial approval
- 6 months agoinvesting.com
Clearmind Medicine stock tumbles on reverse share split plan
7 months agobenzinga.comWhy Is Clearmind Medicine Stock Sliding On Wednesday?
- 7 months agobenzinga.com
Why Is Clearmind Medicine Stock Sliding On Wednesday?
- 7 months agoinvesting.com
Clearmind Medicine stock surges on phase trial results
- 9 months agoinvesting.com
Clearmind Medicine stock falls after Phase I/IIa trial safety update
- 9 months agoinvesting.com
Clearmind Medicine stock surges after Polyrizon intranasal delivery deal
Clearmind Medicine Top Trades
Clearmind Medicine's top trade so far today returned +3.03%, while the top short trade returned -11.28%.
Clearmind Medicine Moving Averages
| 5 Day Moving Average (SMA5) | $5.59 |
|---|---|
| 10 Day Moving Average (SMA10) | $5.81 |
| 20 Day Moving Average (SMA20) | $5.96 |
| 50 Day Moving Average (SMA50) | $3.73 |
| 100 Day Moving Average (SMA100) | $2.82 |
| 200 Day Moving Average (SMA200) | $2.13 |
Clearmind Medicine Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Clearmind Medicine Stock Splits
There have been 5 stock splits for Clearmind Medicine (CMND). The last reverse stock split occured on October 5, 2026 and reduced the outstanding shares at a ratio of 8:1.
| Date | Type | Ratio |
|---|---|---|
| Oct 5, 2026 | Reverse | 8:1 |
| May 21, 2026 | Reverse | 10:1 |
| Dec 15, 2025 | Reverse | 40:1 |
| Nov 28, 2023 | Reverse | 30:1 |
| Jul 3, 2017 | Forward | 1:3.5 |
Clearmind Medicine Dividends
There have been no dividends for Clearmind Medicine (CMND).